 |
|
| Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
| Reply |
|
|
Thread Tools | Display Modes |
08-29-2007, 12:41 PM
|
#1 | |||
|
||||
|
Magnate
|
Merck Serono Announces 18-Month Safety and Efficacy Data of Phase III Trial of Safinamide. Additional trials expected to be initiated (8/ 22/07)
See Focus on Therapies
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Promising Data on Cognitive Effects of Safinamide in Early Parkinson's Disease | Parkinson's Disease Clinical Trials | |||
| Promising Data on Cognitive Effects of Safinamide in Early PD | Parkinson's Disease | |||
| Phase III Data on Safinamide | Parkinson's Disease | |||
| New Serono drug trial | Multiple Sclerosis | |||
| Ceregene announces positive phase 1 results ... | Parkinson's Disease | |||
Safinamide..Merck Serono Announces 18-Month Safety and Efficacy Data Phase III Trial
Linear Mode
